Endothelin Antagonism: A New Era for Resistant Hypertension?
- PMID: 40106534
- DOI: 10.1161/HYPERTENSIONAHA.125.24606
Endothelin Antagonism: A New Era for Resistant Hypertension?
Conflict of interest statement
None.
Comment on
-
Aprocitentan for Blood Pressure Reduction in Black Patients.Hypertension. 2025 Apr;82(4):601-610. doi: 10.1161/HYPERTENSIONAHA.124.24142. Epub 2025 Jan 22. Hypertension. 2025. PMID: 39840441 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
